These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
327 related articles for article (PubMed ID: 21786077)
1. Methamphetamine toxicity and its implications during HIV-1 infection. Silverstein PS; Shah A; Gupte R; Liu X; Piepho RW; Kumar S; Kumar A J Neurovirol; 2011 Oct; 17(5):401-15. PubMed ID: 21786077 [TBL] [Abstract][Full Text] [Related]
2. HIV-1 gp120 and drugs of abuse: interactions in the central nervous system. Silverstein PS; Shah A; Weemhoff J; Kumar S; Singh DP; Kumar A Curr HIV Res; 2012 Jul; 10(5):369-83. PubMed ID: 22591361 [TBL] [Abstract][Full Text] [Related]
3. HIV proteins (gp120 and Tat) and methamphetamine in oxidative stress-induced damage in the brain: potential role of the thiol antioxidant N-acetylcysteine amide. Banerjee A; Zhang X; Manda KR; Banks WA; Ercal N Free Radic Biol Med; 2010 May; 48(10):1388-98. PubMed ID: 20188164 [TBL] [Abstract][Full Text] [Related]
4. Dopamine and its receptors play a role in the modulation of CCR5 expression in innate immune cells following exposure to Methamphetamine: Implications to HIV infection. Basova L; Najera JA; Bortell N; Wang D; Moya R; Lindsey A; Semenova S; Ellis RJ; Marcondes MCG PLoS One; 2018; 13(6):e0199861. PubMed ID: 29944719 [TBL] [Abstract][Full Text] [Related]
5. Estrogen protects against the synergistic toxicity by HIV proteins, methamphetamine and cocaine. Turchan J; Anderson C; Hauser KF; Sun Q; Zhang J; Liu Y; Wise PM; Kruman I; Maragos W; Mattson MP; Booze R; Nath A BMC Neurosci; 2001; 2():3. PubMed ID: 11252157 [TBL] [Abstract][Full Text] [Related]
6. Protective Effects of Ginsenoside Rb1 against Blood-Brain Barrier Damage Induced by Human Immunodeficiency Virus-1 Tat Protein and Methamphetamine in Sprague-Dawley Rats. Li J; Zeng B; Hu X; Li Z; Zhang D; Yang G; Dai J; Zeng X Am J Chin Med; 2018; 46(3):551-566. PubMed ID: 29690789 [TBL] [Abstract][Full Text] [Related]
7. Human immunodeficiency virus-1 Tat protein and methamphetamine interact synergistically to impair striatal dopaminergic function. Maragos WF; Young KL; Turchan JT; Guseva M; Pauly JR; Nath A; Cass WA J Neurochem; 2002 Nov; 83(4):955-63. PubMed ID: 12421368 [TBL] [Abstract][Full Text] [Related]
8. Methamphetamine abuse affects gene expression in brain-derived microglia of SIV-infected macaques to enhance inflammation and promote virus targets. Najera JA; Bustamante EA; Bortell N; Morsey B; Fox HS; Ravasi T; Marcondes MC BMC Immunol; 2016 Apr; 17(1):7. PubMed ID: 27107567 [TBL] [Abstract][Full Text] [Related]
9. Involvement of cytokines in human immunodeficiency virus-1 protein Tat and methamphetamine interactions in the striatum. Theodore S; Cass WA; Maragos WF Exp Neurol; 2006 Jun; 199(2):490-8. PubMed ID: 16510141 [TBL] [Abstract][Full Text] [Related]
10. Effects of HIV-1 Tat and Methamphetamine on Blood-Brain Barrier Integrity and Function Patel S; Leibrand CR; Palasuberniam P; Couraud PO; Weksler B; Jahr FM; McClay JL; Hauser KF; McRae M Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28893794 [TBL] [Abstract][Full Text] [Related]
11. Methamphetamine augment HIV-1 Tat mediated memory deficits by altering the expression of synaptic proteins and neurotrophic factors. Nookala AR; Schwartz DC; Chaudhari NS; Glazyrin A; Stephens EB; Berman NEJ; Kumar A Brain Behav Immun; 2018 Jul; 71():37-51. PubMed ID: 29729322 [TBL] [Abstract][Full Text] [Related]
12. Progress in understanding basal ganglia dysfunction as a common target for methamphetamine abuse and HIV-1 neurodegeneration. Theodore S; Cass WA; Nath A; Maragos WF Curr HIV Res; 2007 May; 5(3):301-13. PubMed ID: 17504172 [TBL] [Abstract][Full Text] [Related]
13. Human Immunodeficiency Virus Type 1 and Methamphetamine-Mediated Mitochondrial Damage and Neuronal Degeneration in Human Neurons. Teodorof-Diedrich C; Spector SA J Virol; 2020 Sep; 94(20):. PubMed ID: 32796068 [TBL] [Abstract][Full Text] [Related]
14. Methamphetamine alters blood brain barrier permeability via the modulation of tight junction expression: Implication for HIV-1 neuropathogenesis in the context of drug abuse. Mahajan SD; Aalinkeel R; Sykes DE; Reynolds JL; Bindukumar B; Adal A; Qi M; Toh J; Xu G; Prasad PN; Schwartz SA Brain Res; 2008 Apr; 1203():133-48. PubMed ID: 18329007 [TBL] [Abstract][Full Text] [Related]
15. Effects of HIV-1 gp120 and TAT-derived microvesicles on endothelial cell function. Hijmans JG; Stockelman K; Levy M; Brewster LM; Bammert TD; Greiner JJ; Connick E; DeSouza CA J Appl Physiol (1985); 2019 May; 126(5):1242-1249. PubMed ID: 30789287 [TBL] [Abstract][Full Text] [Related]
16. HIV-1 TAT protein enhances sensitization to methamphetamine by affecting dopaminergic function. Kesby JP; Najera JA; Romoli B; Fang Y; Basova L; Birmingham A; Marcondes MCG; Dulcis D; Semenova S Brain Behav Immun; 2017 Oct; 65():210-221. PubMed ID: 28495611 [TBL] [Abstract][Full Text] [Related]
17. [HIV-1 neuropathogenesis: therapeutic strategies against neuronal loss induced by gp120/Tat glycoprotein in the central nervous system]. Merino JJ; Montes ML; Blanco A; Bustos MJ; Oreja-Guevara C; Bayon C; Cuadrado A; Lubrini G; Cambron I; Munoz A; Cebolla S; Gutierrez-Fernandez M; Bernardino JI; Arribas JR; Fiala M Rev Neurol; 2011 Jan; 52(2):101-11. PubMed ID: 21271550 [TBL] [Abstract][Full Text] [Related]
18. Human Immunodeficiency Virus Type 1 gp120 and Tat Induce Mitochondrial Fragmentation and Incomplete Mitophagy in Human Neurons. Teodorof-Diedrich C; Spector SA J Virol; 2018 Nov; 92(22):. PubMed ID: 30158296 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of tumor necrosis factor-alpha signaling prevents human immunodeficiency virus-1 protein Tat and methamphetamine interaction. Theodore S; Cass WA; Nath A; Steiner J; Young K; Maragos WF Neurobiol Dis; 2006 Sep; 23(3):663-8. PubMed ID: 16828290 [TBL] [Abstract][Full Text] [Related]
20. Fentanyl dysregulates neuroinflammation and disrupts blood-brain barrier integrity in HIV-1 Tat transgenic mice. Rademeyer KM; R Nass S; Jones AM; Ohene-Nyako M; Hauser KF; McRae M J Neurovirol; 2024 Feb; 30(1):1-21. PubMed ID: 38280928 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]